(FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | |
---|---|---|---|---|---|---|
Assets | ||||||
Current assets | ||||||
Cash, cash equivalents and short term investments | --845.09K | --845.09K | --1.27M | ---- | --0 | --0 |
-Cash and cash equivalents | --845.09K | --845.09K | --1.27M | ---- | --0 | --0 |
-Accounts receivable | --37.26K | --37.26K | --7.63K | ---- | --0 | --0 |
-Due from related parties current | --0 | --0 | --0 | --0.01 | --0.01 | --0.01 |
Total current assets | 9,002,859,900.00%900.29K | 9,002,859,900.00%900.29K | --1.3M | --0.01 | --0.01 | --0.01 |
Non current assets | ||||||
Investment properties | --11.89K | --11.89K | ---- | ---- | --0 | --0 |
Regulatory assets | 372,579,900.00%37.26K | 372,579,900.00%37.26K | --7.63K | --0.01 | --0.01 | --0.01 |
Liabilities | ||||||
Current liabilities | ||||||
-accounts payable | --128.22K | --128.22K | --51.9K | ---- | --0 | --0 |
-Total tax payable | --0 | --0 | --0 | ---- | --0 | --0 |
Current accrued expenses | --45.38K | --45.38K | ---- | ---- | --0 | --0 |
Current liabilities | --173.59K | --173.59K | --51.9K | ---- | --0 | --0 |
Non current liabilities | ||||||
Non current accrued expenses | --1.14M | --1.14M | --1.14M | ---- | --0 | --0 |
Total non current liabilities | --173.59K | --173.59K | --51.9K | --0 | --0 | --0 |
Shareholders'equity | ||||||
Share capital | 24,852,959,900.00%2.49M | 24,852,959,900.00%2.49M | --2.44M | --0.01 | --0.01 | --0.01 |
-common stock | 24,852,959,900.00%2.49M | 24,852,959,900.00%2.49M | --2.44M | --0.01 | --0.01 | --0.01 |
Gains losses not affecting retained earnings | --89.9K | --89.9K | --89.9K | ---- | --0 | --0 |
Total equity | 20,479,829,900.00%2.05M | 20,479,829,900.00%2.05M | --2.44M | --0.01 | --0.01 | --0.01 |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.